Life Scientist > Biotechnology

Proteome-based diagnostic has crop, human applications

14 March, 2002 by Daniella Goldberg

A diagnostic tool for measuring damage to wheat within three minutes has been developed by Sydney-based biotechnology company Proteome Systems, in collaboration with C-Qentec Diagnostics, a subsidiary of Aventis Crop Science Pty Ltd.


Devices celebrate AusBiotech status

14 March, 2002 by Daniella Goldberg

The newly-formed Medical Device Network has become a formal program within industry association AusBiotech.


Dairy research gets a boost

14 March, 2002 by Tanya Hollis

Australia's dairy industry will milk the rewards from a cash injection of almost $1.3 million from the Geoffrey Gardiner Dairy Foundation.


Ambri appointments to boost defence contracts

13 March, 2002 by Daniella Goldberg

Australian biotechnology company Ambri Ltd has appointed two executives to encourage new backing for the company's biological weapons detection contracts.


GTG confident of end of year profit

13 March, 2002 by Tanya Hollis

Genetic Technologies (ASX: GTG) is expecting to finish the year in the black despite posting an interim profit loss yesterday.


'Confident' Progen boosted by manufacturing gains

13 March, 2002 by Pete Young

Half-year results for drug developer Progen Industries show the company enjoyed healthy revenue gains from its contract manufacturing arm while R&D spend rose slightly.


Bionomics heads north again for new partnership

13 March, 2002 by Pete Young

Australia's first publicly-listed pure genomics research company, Bionomics Ltd, has interested a second northern hemisphere partner in its portfolio of patented genes.


Queensland's modest benefactor strikes again

11 March, 2002 by Pete Young

The golden reach of a US philanthropist has touched the Queensland Institute of Medical Research again.


Xenome seals deal with big European

08 March, 2002 by Pete Young

Fresh from inking pacts with two drug development companies, marine toxin specialist Xenome Ltd is on the verge of finalising many more similar deals, says CEO Tony Evans.


New DNA technology could spell precise GMO detection

07 March, 2002 by Daniella Goldberg

At a time when the precise detection of GMOs in food products has been an issue for the Federal government's analytical laboratories, Sydney company BTF Decisive Microbiology has launched bioparticle dispensing technology that it claimed would provide precision in quantitative DNA analysis.


pSivida heralds 'image-raising' appointments

06 March, 2002 by Daniella Goldberg

Platform technology company pSivida has made two new appointments to raise its international profile.


Strong growth continues for PanBio

06 March, 2002 by Pete Young

Diagnostic test company PanBio posted a first half sales jump of 49% to stay on track for a full year revenue target of $16.9 million.


Deloittes aims to flush out fast-moving biotechs

06 March, 2002 by Iain Scott

National accounting firm Deloittes has launched its Technology Fast 50 program for 2002.


BresaGen: stem cell debate won't affect our research

05 March, 2002 by Tanya Hollis

BresaGen has reassured investors its projects are not threatened by potential regulation of stem cell research in Australia.


Panbio pulls back from dendrimer joint venture

04 March, 2002 by Pete Young

A million-dollar collaboration between nano-drug company Starpharma and diagnostics specialist PanBio Ltd has come unstuck.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd